AAAAAA
Results:
1-10
|
Results: 10
Authors:
Bojang, KA
Milligan, PJM
Pinder, M
Vigneron, L
Alloueche, A
Kester, KE
Ballou, WR
Conway, DJ
Reece, WHH
Gothard, P
Yamuah, L
Delchambre, M
Voss, G
Greenwood, BM
Hill, A
McAdam, KPWJ
Tornieporth, N
Cohen, JD
Doherty, T
Citation: Ka. Bojang et al., Efficacy of RTS,S/ASO2 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial, LANCET, 358(9297), 2001, pp. 1927-1934
Authors:
Forney, JR
Magill, AJ
Wongsrichanalai, C
Sirichaisinthop, J
Bautista, CT
Heppner, DG
Miller, RS
Ockenhouse, CF
Gubanov, A
Shafer, R
DeWitt, CC
Quino-Ascurra, HA
Kester, KE
Kain, KC
Walsh, DS
Ballou, WR
Gasser, RA
Citation: Jr. Forney et al., Malaria rapid diagnostic devices: Performance characteristics of the ParaSight F device determined in a multisite field study, J CLIN MICR, 39(8), 2001, pp. 2884-2890
Authors:
Berman, JD
Nielsen, R
Chulay, JD
Dowler, M
Kain, KC
Kester, KE
Williams, J
Whelen, AC
Shmuklarsky, MJ
Citation: Jd. Berman et al., Causal prophylactic efficacy of atovaquone-proguanil (Malarone (TM)) in a human challenge model, T RS TROP M, 95(4), 2001, pp. 429-432
Authors:
Kester, KE
McKinney, DA
Tornieporth, N
Ockenhouse, CF
Heppner, DG
Hall, T
Krzych, U
Delchambre, M
Voss, G
Dowler, MG
Palensky, J
Wittes, J
Cohen, J
Ballou, WR
Citation: Ke. Kester et al., Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria, J INFEC DIS, 183(4), 2001, pp. 640-647
Authors:
Kester, KE
Visvesara, GS
McEvoy, P
Citation: Ke. Kester et al., Organism responsible for nodular cutaneous microsporidiosis in a patient with AIDS, ANN INT MED, 133(11), 2000, pp. 925-925
Authors:
Keitel, WA
Kester, KE
Atmar, RL
White, AC
Bond, NH
Holland, CA
Krzych, U
Palmer, DR
Egan, A
Diggs, C
Ballou, WR
Hall, BF
Kaslow, D
Citation: Wa. Keitel et al., Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein I (msp-1(19)) and T helper epitopes of tetanus toxoid, VACCINE, 18(5-6), 1999, pp. 531-539
Authors:
Lalvani, A
Moris, P
Voss, G
Pathan, AA
Kester, KE
Brookes, R
Lee, E
Koutsoukos, M
Plebanski, M
Delchambre, M
Flanagan, KL
Carton, C
Slaoui, M
Van Hoecke, C
Ballou, WR
Hill, AVS
Cohen, J
Citation: A. Lalvani et al., Potent induction of focused Th1-type cellular and humoral immune responsesby RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine, J INFEC DIS, 180(5), 1999, pp. 1656-1664
Authors:
Heppner, G
Gasser, RA
Kester, KE
Citation: G. Heppner et al., Primaquine prophylaxis against malaria, ANN INT MED, 130(6), 1999, pp. 536-536
Authors:
Doherty, JF
Pinder, M
Tornieporth, N
Carton, C
Vigneron, L
Milligan, P
Ballou, WR
Holland, CA
Kester, KE
Voss, G
Momin, P
Greenwood, BM
McAdam, KPWJ
Cohen, J
Citation: Jf. Doherty et al., A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS,S/SBAS2 in semi-immune adults in the Gambia, AM J TROP M, 61(6), 1999, pp. 865-868
Authors:
Gozalo, A
Lucas, C
Cachay, M
Wellde, BT
Hall, T
Bell, B
Wood, J
Watts, D
Wooster, M
Lyon, JA
Moch, JK
Haynes, JD
Williams, JS
Holland, C
Watson, E
Kester, KE
Kaslow, DC
Ballou, WR
Citation: A. Gozalo et al., Passive transfer of growth-inhibitory antibodies raised against yeast-expressed recombinant Plasmodium falciparum merozoite surface protein-1(19), AM J TROP M, 59(6), 1998, pp. 991-997
Risultati:
1-10
|